| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 136 | 150 | 4,030 | $100 | $5.9M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 51 | 170 | 4,660 | $300 | $2.6M |
| A0431 | Ambulance service, conventional air services, transport, one way (rotary wing) | 13 | 20 | 530 | $2,040 | $2.6M |
| 81479 | Use 81479 to report a molecular pathology procedure that does not have a specific code. | 5 | 10 | 760 | $50 | $2M |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 7 | 480 | 4,510 | $90 | $1.8M |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 7 | 10 | 890 | $1,920 | $1.7M |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 14 | 660 | 460 | $90 | $1.5M |
| 99285 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a high level of medical decision making. | 40 | 580 | 510 | $100 | $1.3M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6 | 20 | 260 | $1,470 | $1.1M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 14 | 140 | 1,130 | $90 | $1.1M |